Pfizer News

Perrigo Co. CEO Joe Papa said 10 percent of his pharmaceutical company's hires have come from layoffs, including some from drug manufacturer Pfizer Inc.

Companies Featured in This Article: Pfizer, Monsanto, Sara Lee, CSX, Mylan Laboratories, Cohen & Steers Many U.S. companies are quietly changing their bylaws to pry more information out of activist investors ...

Genentech reported yesterday that its first-quarter overall revenue rose nearly 8%. Its top drugs, including cancer treatments Avastin and Rituxan, posted blowout double-digit sales growth.

Pfizer has agreed to pay $975,000 in civil penalties to resolve alleged violations of the Clean Air Act at its former manufacturing plant in Groton, Connecticut, according to a release by the US Department of ...

Big pharma makes strange bedfellows. Pfizer , Merck , and Eli Lilly announced yesterday morning that they've launched a joint venture of sorts called, "Enlight Biosciences" . They're doing it with the help of ...

Pfizer Inc. is cutting 275 jobs at its biggest manufacturing plant, in Michigan, in its latest restructuring move.

Melior Discovery Inc. signed its second deal with pharmaceutical giant Pfizer Inc.

Pfizer Inc. has announced that it will support continuing medical education courses at academic medical centers, teaching hospitals and in programs sponsored by associations, medical societies and community ...

Pfizer Inc said its epilepsy drugs do not increase the risk of suicidal behavior and should be exempt from tougher warnings being sought for similar medications.

Enlight Biosciences, a new Boston-based company conceived by PureTech Ventures together with several major pharmaceutical companies, announced that it will direct up to $39M to advance breakthrough technologies ...

Australia's regenerative medicine company, Mesoblast Limited , announced highly significant preclinical trial results of the adult stem cell technology platform for the treatment of eye diseases associated with ...

Anti-seizure drugs used to treat epilepsy carry an increased risk of suicidal thoughts and behavior but not enough to warrant a black box warning, a U.S. advisory panel concluded on Thursday.

Yesterday, the FDA announced that on Aug. 11 it will finally put the "approvable letter" out of its misery.

Indianapolis drugmaker Eli Lilly and Co. is joining forces with two industry rivals to save money and get more medicines to market faster.

Former Veterans Affairs Secretary Anthony J. Principi contacted colleagues at his old agency as the chief lobbyist for drug maker Pfizer Inc.

But alas, it wasn't meant to be. Teva announced Monday that a double dose of its multiple sclerosis drug Copaxone didn't work any better than the currently available dose.

Belgian brewer InBev on Monday announced its latest move in its quest to buy Anheuser-Busch, putting up an alternative slate of directors that includes a descendant of the founding Busch family.

Once a pharma gets its first drug approved, one of the hardest things to do is to capture the spoils.

State and federal environmental officials are trying to determine if the release of toxins from a wastewater lagoon at a Pfizer Inc.

The federal government has approved a new Pfizer Inc. antibiotic for dogs and cats that next year will be manufactured in Portage.